🎯
LATEST VERIFIED ALGORITHMIC EXECUTION
Quantitative engine captured a net profit of +19.26% on $OC in just 23h 32m.
ABT
$ABT
🔒 US EquitiesAbbott Laboratories
AVG HISTORICAL GAP
-0.82%
MAX GAP RECORD
-10.93%
🔒 PRO INSTITUTIONAL
AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡
SENTINEL HISTORICAL GAP VIEWER
// $ABT
📊 1-YEAR TIMELINE (GAPS PLOTTED)
🔮 SIMULATE SETUP 🔒
GAP INSPECTION // PLAYBACK PROTOCOL
$ABT
HISTORICAL GAP OCCURRENCE
Analyzing price jump between T-1 close and opening auction.
EVENT DATE—
GAP MAGNITUDE—
T-1 CLOSE—
OPEN PRICE—
AI DIRECTIONPRO ONLY 🔒
Bullish Opening Gap
Bearish Opening Gap
T-1 Close Baseline
CATALYSTS & GAP HISTORY
| Oct 21, 2026 Earnings Release 2026-10-21 (BEFORE OPEN (08:00)) |
-1.11%
|
| Jul 16, 2026 Earnings Release 2026-07-16 (BEFORE OPEN) |
+6.74%
|
| Apr 15, 2026 Earnings Release 2026-04-15 (AFTER CLOSE) |
-4.36%
|
| Jan 22, 2026 Earnings Release 2026-01-22 (BEFORE OPEN) |
-10.93%
|
| Oct 15, 2025 Earnings Release 2025-10-15 (BEFORE OPEN) |
-3.52%
|
| Jul 23, 2025 Earnings Release 2025-07-23 (BEFORE OPEN) |
+0.58%
|
| Apr 16, 2025 Earnings Release 2025-04-16 (BEFORE OPEN) |
+2.76%
|
| Jan 22, 2025 Earnings Release 2025-01-22 (BEFORE OPEN) |
-2.28%
|
VOLATILITY & GAP BIAS
AVG GAP MOVE
3.1%
Bullish Gaps (4)
Bearish Gaps (9)
Neutral / Flat (3)
📖 Intelligence Summary
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis…
NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗